publication venue for
- Management of ductal carcinoma in situ of the breast. Provincial Breast Cancer Disease Site Group.. 2:312-319. 1998
- Use of granulocyte colony-stimulating factor (G-CSF) in patients receiving myelosuppressive chemotherapy for the treatment of cancer. Provincial Systemic Treatment Disease Site Group.. 2:179-190. 1998
- Epirubicin, alone or in combination chemotherapy, for metastatic breast cancer. Provincial Breast Cancer Disease Site Group and the Provincial Systemic Treatment Disease Site Group.. 2:140-146. 1998
- Use of strontium-89 in endocrine-refractory prostate cancer metastatic to bone. Provincial Genitourinary Cancer Disease Site Group.. 2:79-87. 1998
- Use of preoperative chemotherapy with or without postoperative radiotherapy in technically resectable stage IIIA non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.. 2:32-39. 1998
- Adjuvant therapy for stage II colon cancer after complete resection. Provincial Gastrointestinal Disease Site Group.. 1:379-392. 1997
- Erratum: Surgical management of early stage invasive breast cancer (stage I and II) (Cancer Prevention and Control (1997) 1 (10-17)). 1:132. 1997
- Breast irradiation in women with early stage invasive breast cancer following breast conservation surgery. Provincial Breast Disease Site Group.. 1:228-240. 1997
- Erythropoietin in the management of patients with nonhematologic cancer receiving chemotherapy. Systemic Treatment Program Committee.. 1:241-248. 1997
- Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.. 1:249-259. 1997
- Chemotherapy in stage IV (metastatic) non-small-cell lung cancer. Provincial Lung Disease Site Group.. 1:18-27. 1997
- Surgical management of early stage invasive breast cancer (stage I and II). Provincial Breast Disease Site Group.. 1:10-17. 1997
- The clinical practice guideline: an evolving health care technology.. 1:7-8. 1997